Src inhibitor Bosutinib, Purity ≥98%

Cat. No.: X24-06-ZQ328

Src inhibitor Bosutinib, Purity ≥98%

Synonym: 380843-75-4; Src inhibitor; SKI-606; SKI606

  • MDL: MFCD07367846
  • CAS Number: 380843-75-4
  • Compound CID: 5328940
Product Size
10 mg; 50 mg; 100 mg; 200 mg
Price
Datasheet
MSDS
Properties
Description
Bosutinib, soluble in DMSO and ethanol and insoluble in water, blocks the activity of Src kinases, which are involved in various cellular processes such as growth, differentiation, and survival, and have been implicated in the progression of several cancers and other diseases. It targets Abl and Src.
Molecular Weight
530.4
Molecular Formula
C26H29Cl2N5O3
Targets
Abl: 1 nM; Src: 1.2 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 93 mg/mL (175.31 mM); Water: Insoluble; Ethanol: 2 mg/mL (3.77 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
Bosutinib is a Src inhibitor researched for its applicability in treating Src-associated malignancies.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0